The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer
CLDN18.2 has become a major new target in gastric cancer targeted therapy. Its clinical trials and development are advancing quickly, with various types of drugs available. In the future, more released data may make treatment strategies better and give new treatment options to gastric cancer patients.
Authors
- Xingcan Fan
- Wenxiao Zhang (ORCID: https://orcid.org/0000-0001-7052-5011)
- Yang Song (ORCID: https://orcid.org/0000-0001-7716-9216)
- Qiuyu Liao
- Zhen Wei
- Gang Liu
Institutions
- Tianjin Medical University General Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1097/coc.0000000000001307
- Primary Topic
- Barrier Structure and Function Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00